Topical use of aprotinin in open heart operations.

[1]  W. van Oeveren,et al.  Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypass. , 1991, The Annals of thoracic surgery.

[2]  M. Jochum,et al.  Aprotinin and its target enzymes in vitro and in vivo , 1990 .

[3]  H. Hoffmeister.  Blood Saving in Open Heart Surgery , 1990 .

[4]  V. Boddi,et al.  High-dose aprotinin: hemostatic effects in open heart operations. , 1989, The Annals of thoracic surgery.

[5]  J. Tinker.  Cardiopulmonary Bypass: Current Concepts and Controversies , 1989 .

[6]  G. Fraedrich,et al.  Reduction of Blood Transfusion Requirement in Open Heart Surgery by Administration of High Doses of Aprotinin - Preliminary Results , 1989, The Thoracic and cardiovascular surgeon.

[7]  A. Montoya,et al.  Management of Blood Loss and Heparin Rebound Following Cardiopulmonary Bypass , 1989, Seminars in thrombosis and hemostasis.

[8]  F. Sebening,et al.  Reduction of Homologous Blood Requirement in Cardiac Surgery by Intraoperative Aprotinin Application - Clinical Experience in 152 Cardiac Surgical Patients , 1989, The Thoracic and cardiovascular surgeon.

[9]  D. Cosgrove,et al.  Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). , 1989, The Journal of thoracic and cardiovascular surgery.

[10]  K. M. Taylor,et al.  EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERY , 1987, The Lancet.

[11]  W. van Oeveren,et al.  Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. , 1987, The Annals of thoracic surgery.

[12]  R. Wilson,et al.  Hemostasis Changes During Cardiopulmonary Bypass Surgery , 1985, Seminars in thrombosis and hemostasis.

[13]  R. Bick.  Hemostasis Defects Associated with Cardiac Surgery, Prosthetic Devices, and Other Extracorporeal Circuits , 1985, Seminars in thrombosis and hemostasis.

[14]  E. Hessel,et al.  Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release. , 1980, Blood.